Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Radcliffe Medical Media
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/130d3392c78e4cfd8984f9006ed84963 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:130d3392c78e4cfd8984f9006ed84963 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:130d3392c78e4cfd8984f9006ed849632021-12-04T16:04:14ZConsensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes10.15420/ecr.2020.521758-37641758-3756https://doaj.org/article/130d3392c78e4cfd8984f9006ed849632021-04-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2020.52https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.Jack Wei Chieh TanDavid SimJunya AkoWael AlmahmeedMark E CooperJamshed J DalalChaicharn DeerochanawongDavid Wei Chun HuangSofian JoharUpendra KaulSin Gon KimNatalie KohAlice Pik-Shan KongRungroj KrittayaphongBernard KwokBien J MatawaranQuang Ngoc NguyenLoke Meng OngJin Joo ParkYongde PengDavid KL QuekKetut SuastikaNorlela SukorBoon Wee TeoChee Kiang TeohJian ZhangEugenio B ReyesSu Yen GohRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 16, Iss , Pp - (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
| spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| description |
The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease. |
| format |
article |
| author |
Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh |
| author_facet |
Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh |
| author_sort |
Jack Wei Chieh Tan |
| title |
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_short |
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_full |
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_fullStr |
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_full_unstemmed |
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_sort |
consensus recommendations by the asian pacific society of cardiology: optimising cardiovascular outcomes in patients with type 2 diabetes |
| publisher |
Radcliffe Medical Media |
| publishDate |
2021 |
| url |
https://doaj.org/article/130d3392c78e4cfd8984f9006ed84963 |
| work_keys_str_mv |
AT jackweichiehtan consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidsim consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT junyaako consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT waelalmahmeed consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT markecooper consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jamshedjdalal consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT chaicharndeerochanawong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidweichunhuang consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT sofianjohar consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT upendrakaul consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT singonkim consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT nataliekoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT alicepikshankong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT rungrojkrittayaphong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT bernardkwok consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT bienjmatawaran consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT quangngocnguyen consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT lokemengong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jinjoopark consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT yongdepeng consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidklquek consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT ketutsuastika consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT norlelasukor consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT boonweeteo consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT cheekiangteoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jianzhang consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT eugeniobreyes consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT suyengoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes |
| _version_ |
1718372658801803264 |